|
US9006175B2
(en)
|
1999-06-29 |
2015-04-14 |
Mannkind Corporation |
Potentiation of glucose elimination
|
|
US7464706B2
(en)
|
1999-07-23 |
2008-12-16 |
Mannkind Corporation |
Unit dose cartridge and dry powder inhaler
|
|
US7305986B1
(en)
|
1999-07-23 |
2007-12-11 |
Mannkind Corporation |
Unit dose capsules for use in a dry powder inhaler
|
|
GB0201677D0
(en)
|
2002-01-25 |
2002-03-13 |
Glaxo Group Ltd |
Medicament dispenser
|
|
WO2003080149A2
(en)
|
2002-03-20 |
2003-10-02 |
Mannkind Corporation |
Inhalation apparatus
|
|
PL1786784T3
(pl)
|
2004-08-20 |
2011-04-29 |
Mannkind Corp |
Kataliza syntezy diketopiperazyn
|
|
KR101644250B1
(ko)
|
2004-08-23 |
2016-07-29 |
맨카인드 코포레이션 |
약물 전달용 디케토피페라진염, 디케토모르포린염 또는 디케토디옥산염
|
|
US8763605B2
(en)
|
2005-07-20 |
2014-07-01 |
Manta Devices, Llc |
Inhalation device
|
|
CN104324362B
(zh)
|
2005-09-14 |
2018-04-24 |
曼金德公司 |
以提高活性试剂对结晶微粒表面的亲和力为基础的药物配制方法
|
|
USD613848S1
(en)
|
2006-02-16 |
2010-04-13 |
Glaxo Group Limited |
Inhalation device
|
|
IN2015DN00888A
(https=)
|
2006-02-22 |
2015-07-10 |
Mannkind Corp |
|
|
US11224704B2
(en)
*
|
2007-07-06 |
2022-01-18 |
Manta Devices, Llc |
Dose delivery device for inhalation
|
|
EP2011536A1
(en)
*
|
2007-07-06 |
2009-01-07 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Inhaler
|
|
JP5528336B2
(ja)
*
|
2007-07-06 |
2014-06-25 |
マンタ デバイシス，エルエルシー |
デリバリー装置及び関連方法
|
|
GB0719299D0
(en)
|
2007-10-03 |
2007-11-14 |
Optinose As |
Nasal delivery devices
|
|
EP2534957B1
(en)
|
2007-12-14 |
2015-05-27 |
AeroDesigns, Inc |
Delivering aerosolizable products
|
|
WO2009121020A1
(en)
*
|
2008-03-27 |
2009-10-01 |
Mannkind Corporation |
A dry powder inhalation system
|
|
AU2015201158B2
(en)
*
|
2008-03-27 |
2017-04-13 |
Mannkind Corporation |
A dry powder inhalation system
|
|
JP5462152B2
(ja)
*
|
2008-04-17 |
2014-04-02 |
帝人ファーマ株式会社 |
定量噴霧式吸入器用吸入補助器具
|
|
ES2929343T3
(es)
|
2008-06-13 |
2022-11-28 |
Mannkind Corp |
Inhalador de polvo seco accionado por aspiración para la administración de fármacos
|
|
US8485180B2
(en)
|
2008-06-13 |
2013-07-16 |
Mannkind Corporation |
Dry powder drug delivery system
|
|
KR101628410B1
(ko)
*
|
2008-06-20 |
2016-06-08 |
맨카인드 코포레이션 |
흡입 활동에 관한 실시간 프로파일링을 위한 대화형 장치 및 방법
|
|
US20100032444A1
(en)
*
|
2008-08-07 |
2010-02-11 |
Wanda Sheffield |
Dispenser For An Orally Dissolvable Strip
|
|
TWI614024B
(zh)
|
2008-08-11 |
2018-02-11 |
曼凱公司 |
超快起作用胰島素之用途
|
|
US8314106B2
(en)
|
2008-12-29 |
2012-11-20 |
Mannkind Corporation |
Substituted diketopiperazine analogs for use as drug delivery agents
|
|
NZ574666A
(en)
*
|
2009-02-05 |
2009-04-30 |
Nexus6 Ltd |
A medicament inhaler holder that uses optical means to count and display the number of doses used
|
|
DK2400950T3
(da)
|
2009-02-26 |
2019-07-29 |
Glaxo Group Ltd |
Farmaceutiske formuleringer omfattende 4-{(1 r)-2-[(6-{2-[(2,6-dichlorbenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol
|
|
DK2405963T3
(da)
|
2009-03-11 |
2013-12-16 |
Mannkind Corp |
Apparat, system og fremgangsmåde til at måle modstand i en inhalator
|
|
HUE025075T2
(en)
|
2009-05-18 |
2016-01-28 |
Norton Healthcare Ltd |
Dry powder inhaler
|
|
DK2684577T3
(en)
*
|
2009-05-18 |
2015-11-16 |
Norton Healthcare Ltd |
A dry powder inhaler
|
|
JP5667170B2
(ja)
*
|
2009-05-18 |
2015-02-12 |
ノートン・ヘルスケアー リミテッド |
ドライパウダー吸入器
|
|
GB0910537D0
(en)
*
|
2009-06-18 |
2009-07-29 |
Ivax Pharmaceuticals Ireland |
Inhaler
|
|
CN104721825B
(zh)
|
2009-06-12 |
2019-04-12 |
曼金德公司 |
具有确定比表面积的二酮哌嗪颗粒
|
|
TR201002877A2
(tr)
*
|
2010-04-13 |
2011-10-21 |
Bi̇lgi̇ç Mahmut |
Blister ambalaj içeren inhalasyon cihazı
|
|
WO2011129788A1
(en)
*
|
2010-04-13 |
2011-10-20 |
Mahmut Bilgic |
User-friendly dry powder inhaler
|
|
US9345848B2
(en)
|
2009-10-20 |
2016-05-24 |
Sima Patent Ve Lisanslama Hizmetleri Ltd. Sti. |
Dry powder inhaler
|
|
WO2011056889A1
(en)
|
2009-11-03 |
2011-05-12 |
Mannkind Corporation |
An apparatus and method for simulating inhalation efforts
|
|
BR112012011249A2
(pt)
*
|
2009-11-13 |
2016-04-12 |
Schering Corp |
dispensador de pó, droga, e, produto de droga
|
|
GB0921075D0
(en)
|
2009-12-01 |
2010-01-13 |
Glaxo Group Ltd |
Novel combination of the therapeutic agents
|
|
EP2566549B1
(en)
*
|
2010-04-13 |
2017-03-22 |
Sima Patent ve Lisanslama Hizmetleri Ltd.Sti. |
Dry powder inhaler mouthpiece button
|
|
EP2566550A1
(en)
*
|
2010-04-13 |
2013-03-13 |
Mahmut Bilgic |
Inhaler which creates turbulance
|
|
JP5860869B2
(ja)
*
|
2010-04-13 |
2016-02-16 |
シマ パテント ヴェ リサンスラマヒズメトレリ リミテッド シルケティ |
吸入デバイス
|
|
IL223742A
(en)
|
2010-06-21 |
2016-06-30 |
Mannkind Corp |
A dry powder inhaler and preparation for it
|
|
ES2705494T3
(es)
|
2010-08-31 |
2019-03-25 |
Glaxosmithkline Ip Dev Ltd |
Productos farmacológicos para la inhalación de polvo seco que presentan propiedades de control de la humedad y procedimientos de administración de los mismos
|
|
AU2011298315B2
(en)
|
2010-08-31 |
2014-08-28 |
Glaxo Group Limited |
Dry powder inhalation drug products exhibiting moisture control properties and methods of administering the same
|
|
AU2012236150B2
(en)
|
2011-04-01 |
2016-03-31 |
Mannkind Corporation |
Blister package for pharmaceutical cartridges
|
|
CN103561731A
(zh)
|
2011-06-08 |
2014-02-05 |
葛兰素集团有限公司 |
包含芜地溴铵的干粉吸入器组合物
|
|
MX2013014399A
(es)
|
2011-06-08 |
2014-03-21 |
Glaxo Group Ltd |
Combinacion que comprende umeclidinio y un corticosteroide.
|
|
WO2012174472A1
(en)
|
2011-06-17 |
2012-12-20 |
Mannkind Corporation |
High capacity diketopiperazine microparticles
|
|
BR112014009686A2
(pt)
|
2011-10-24 |
2018-08-07 |
Mannkind Corp |
composição analgésica inalável, pó seco e método para tratar dor
|
|
EA026450B1
(ru)
|
2011-11-25 |
2017-04-28 |
Махмут Билджик |
Ингалятор
|
|
CN104470503A
(zh)
|
2012-04-13 |
2015-03-25 |
葛兰素史克知识产权开发有限公司 |
聚集粒子
|
|
US8989896B2
(en)
*
|
2012-04-24 |
2015-03-24 |
Arthur E. Brown |
High efficiency automated pharmaceutical dispenser
|
|
EP2662105B1
(de)
|
2012-05-09 |
2017-01-18 |
Boehringer Ingelheim International GmbH |
Zerstäuber
|
|
JP6052400B2
(ja)
*
|
2012-05-25 |
2016-12-27 |
アーヴェン イラチュ サナイ ヴェ ティヂャレット エー． エス．Ａｒｖｅｎ Ｉｌａｃ Ｓａｎａｙｉ Ｖｅ Ｔｉｃａｒｅｔ Ａ．Ｓ． |
空気流路のある内側本体を備える吸入器
|
|
US9631511B2
(en)
*
|
2012-06-27 |
2017-04-25 |
Ecoservices, Llc |
Engine wash apparatus and method
|
|
CN104619369B
(zh)
|
2012-07-12 |
2018-01-30 |
曼金德公司 |
干粉药物输送系统和方法
|
|
US10159644B2
(en)
|
2012-10-26 |
2018-12-25 |
Mannkind Corporation |
Inhalable vaccine compositions and methods
|
|
GB201222679D0
(en)
|
2012-12-17 |
2013-01-30 |
Glaxo Group Ltd |
Pharmaceutical combination products
|
|
AU2014228415B2
(en)
|
2013-03-15 |
2018-08-09 |
Mannkind Corporation |
Microcrystalline diketopiperazine compositions and methods
|
|
AU353848S
(en)
|
2013-04-11 |
2014-02-25 |
Glaxo Group Ltd |
Inhaler
|
|
MX375448B
(es)
|
2013-07-18 |
2025-03-06 |
Mannkind Corp |
Composiciones farmacéuticas en polvo seco estables al calor y métodos.
|
|
US11446127B2
(en)
|
2013-08-05 |
2022-09-20 |
Mannkind Corporation |
Insufflation apparatus and methods
|
|
USD744087S1
(en)
|
2013-10-01 |
2015-11-24 |
Mahmut Bilgic |
Dry powder inhaler
|
|
US10307464B2
(en)
|
2014-03-28 |
2019-06-04 |
Mannkind Corporation |
Use of ultrarapid acting insulin
|
|
WO2015168572A2
(en)
|
2014-05-02 |
2015-11-05 |
Manta Devices, Llc |
Delivery device and related methods
|
|
JP6291342B2
(ja)
*
|
2014-05-13 |
2018-03-14 |
アークレイ株式会社 |
測定装置及び測定装置の動作方法
|
|
EP3148521B1
(en)
|
2014-05-28 |
2019-12-18 |
GlaxoSmithKline Intellectual Property Development Limited |
Fluticasone furoate in the treatment of copd
|
|
US10561806B2
(en)
|
2014-10-02 |
2020-02-18 |
Mannkind Corporation |
Mouthpiece cover for an inhaler
|
|
US11116918B2
(en)
*
|
2015-03-02 |
2021-09-14 |
Abithas, Inc. |
Delivery system for metered dose inhalers
|
|
GB201503720D0
(en)
|
2015-03-05 |
2015-04-22 |
Glaxosmithkline Ip No 2 Ltd |
Chemical compound
|
|
KR20170123315A
(ko)
|
2015-03-11 |
2017-11-07 |
글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 |
Tslp 결합 단백질
|
|
GB201504689D0
(en)
|
2015-03-19 |
2015-05-06 |
Glaxosmithkline Ip Dev Ltd |
Chemical compounds
|
|
US9500435B2
(en)
*
|
2015-04-21 |
2016-11-22 |
Jui-Fu Tseng |
Spherical particle dispenser
|
|
EP3766878B1
(en)
|
2015-06-15 |
2022-03-16 |
GlaxoSmithKline Intellectual Property Development Limited |
Nrf2 regulators
|
|
CA2988373A1
(en)
|
2015-06-15 |
2016-12-22 |
Glaxosmithkline Intellectual Property Development Limited |
Nrf2 regulators
|
|
SI3782996T1
(sl)
|
2015-06-15 |
2024-06-28 |
Glaxosmithkline Intellectual Property Development Limited |
Nrf2 regulatorji
|
|
USD861852S1
(en)
*
|
2015-08-13 |
2019-10-01 |
Adherium (Nz) Limited |
Compliance monitor for a medicament inhaler
|
|
TW201722965A
(zh)
|
2015-08-16 |
2017-07-01 |
葛蘭素史密斯克藍智慧財產發展有限公司 |
用於抗菌應用之化合物
|
|
KR20150112912A
(ko)
*
|
2015-09-17 |
2015-10-07 |
최성숙 |
바이오센서 스트립의 저장장치 및 이를 포함하는 혈당측정기
|
|
US10364256B2
(en)
|
2015-10-06 |
2019-07-30 |
Glaxosmithkline Intellectual Property Development Limited |
Biaryl pyrazoles as NRF2 regulators
|
|
WO2017060855A1
(en)
|
2015-10-06 |
2017-04-13 |
Glaxosmithkline Intellectual Property Development Limited |
Arylcyclohexyl pyrazoles as nrf2 regulators
|
|
WO2017201463A1
(en)
|
2016-05-19 |
2017-11-23 |
Mannkind Corporation |
Apparatus, system and method for detecting and monitoring inhalations
|
|
US11119158B2
(en)
|
2016-06-17 |
2021-09-14 |
Thin Film Electronics Asa |
Wireless mechanism for detecting an open or closed container, and methods of making and using the same
|
|
GB201614940D0
(en)
|
2016-09-02 |
2016-10-19 |
Glaxosmithkline Intellectual Property (No 2) Ltd |
Chemical compounds
|
|
GB201614939D0
(en)
|
2016-09-02 |
2016-10-19 |
Glaxosmithkline Ip Dev Ltd |
Crystalline hydrate
|
|
GB201614934D0
(en)
|
2016-09-02 |
2016-10-19 |
Glaxosmithkline Intellectual Property (No 2) Ltd |
Chemical compounds
|
|
RU2019110821A
(ru)
|
2016-09-20 |
2020-10-22 |
Глэксосмитклайн Интеллекчуал Проперти (Но.2) Лимитед |
Антагонисты trpv4
|
|
JP2019532054A
(ja)
|
2016-09-20 |
2019-11-07 |
グラクソスミスクライン、インテレクチュアル、プロパティー、（ナンバー２）、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ （Ｎｏ．２） Ｌｉｍｉｔｅｄ |
Ｔｒｐｖ４拮抗薬
|
|
TW201825458A
(zh)
|
2016-09-20 |
2018-07-16 |
英商葛蘭素史克智慧財產（第二）有限公司 |
Ｔｒｐｖ４拮抗劑
|
|
USD818112S1
(en)
*
|
2016-10-19 |
2018-05-15 |
Reciprocal Labs Corporation |
Usage monitoring attachment for a dry powder inhaler
|
|
CN108779108A
(zh)
|
2016-12-06 |
2018-11-09 |
葛兰素史密斯克莱知识产权发展有限公司 |
3-(2,3-二氢-1h-茚-5-基)丙酸衍生物和它们作为nrf2调节剂的用途
|
|
US10426698B2
(en)
*
|
2016-12-08 |
2019-10-01 |
Breeden Brothers, LLC |
Pill container with cap
|
|
EP3551621A1
(en)
|
2016-12-12 |
2019-10-16 |
GlaxoSmithKline Intellectual Property Development Limited |
N-aryl pyrazoles as nrf2 regulators
|
|
WO2018109641A1
(en)
|
2016-12-12 |
2018-06-21 |
Glaxosmithkline Intellectual Property Development Limited |
3-carboxylic acid pyrroles as nrf2 regulators
|
|
JP2020502136A
(ja)
|
2016-12-14 |
2020-01-23 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ |
Ｎｒｆ２レギュレーターとしてのビスアリールアミド
|
|
EP3555068B1
(en)
|
2016-12-14 |
2020-12-02 |
GlaxoSmithKline Intellectual Property Development Limited |
3-oxo-1,4-diazepinyle compounds as nrf2 activators
|
|
JP2020502123A
(ja)
|
2016-12-14 |
2020-01-23 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ |
Ｎｒｆ２アクチベーターとしてのビスアリール複素環
|
|
CA3044773A1
(en)
|
2016-12-15 |
2018-06-21 |
Glaxosmithkline Intellectual Property Development Limited |
Nrf2 activators
|
|
US11059816B2
(en)
|
2016-12-15 |
2021-07-13 |
Glaxosmithkline Intellectual Property Development Limited |
Ether linked triazoles as NRF2 activators
|
|
CN108622469B
(zh)
*
|
2017-03-24 |
2023-08-15 |
李和伟 |
一种独立包装的履带式给药器
|
|
EP3600391A1
(en)
|
2017-03-31 |
2020-02-05 |
GlaxoSmithKline Intellectual Property Development Limited |
Immunogenic composition, use and method of treatment
|
|
US11281816B2
(en)
*
|
2020-07-21 |
2022-03-22 |
Fresh Health Inc. |
Systems and methods for manufacturing personalized oral care devices
|
|
US12279921B2
(en)
|
2017-06-30 |
2025-04-22 |
Fresh Health Inc. |
Cleaning device for teeth
|
|
EP3888467A1
(de)
*
|
2017-07-03 |
2021-10-06 |
Weber Maschinenbau GmbH Breidenbach |
Bereitstellen von bahnförmigem zwischenblattmaterial an einem schneidbereich
|
|
JP1600829S
(https=)
*
|
2017-08-24 |
2018-04-02 |
|
|
|
JP1600828S
(https=)
*
|
2017-08-24 |
2018-04-02 |
|
|
|
JP1600827S
(https=)
*
|
2017-08-24 |
2018-04-02 |
|
|
|
US20190076607A1
(en)
*
|
2017-09-13 |
2019-03-14 |
Lupin Atlantis Holdings Sa |
Inhaler and mesh for an inhaler
|
|
US20210177861A1
(en)
|
2017-12-11 |
2021-06-17 |
Glaxosmithkline Intellectual Property Development Limited |
Nrf2 activator for the treatment of acute lung injury, acute respiratory distress syndrome and multiple organ dysfunction syndrome
|
|
WO2019116231A1
(en)
|
2017-12-11 |
2019-06-20 |
Glaxosmithkline Intellectual Property Development Limited |
Nrf2 activator for the treatment of acute lung injury, acute respiratory distress syndrome and multiple organ dysfunction syndrome
|
|
GB201720989D0
(en)
|
2017-12-15 |
2018-01-31 |
Glaxosmithkline Ip Dev Ltd |
Chemical compounds
|
|
CA3088347A1
(en)
|
2018-01-17 |
2019-07-25 |
Glaxosmithkline Intellectual Property Development Limited |
Pi4kiii.beta. inhibitors
|
|
JP2021524469A
(ja)
|
2018-05-23 |
2021-09-13 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ |
Ｎｒｆ２アクチベーターとしてのインダン
|
|
GB201812671D0
(en)
|
2018-08-03 |
2018-09-19 |
Coalesce Product Dev Ltd |
An inhaler device
|
|
EP3955999B1
(en)
*
|
2018-09-03 |
2024-08-14 |
Ttp Plc |
Medicament delivery device
|
|
EP3852850B1
(en)
*
|
2018-09-17 |
2022-06-29 |
Vectura Delivery Devices Limited |
Dry powder inhaler
|
|
JP7686569B2
(ja)
|
2019-04-15 |
2025-06-02 |
フレッシュ ヘルス インコーポレイテッド |
個人化された口腔ケアのためのシステムおよび方法
|
|
GB201908536D0
(en)
|
2019-06-13 |
2019-07-31 |
Glaxosmithkline Ip Dev Ltd |
Compounds
|
|
GB2589635B
(en)
|
2019-12-06 |
2021-12-01 |
Merxin Ltd |
Elongate form medicament carrier and medicament dispenser
|
|
ES3008186T3
(en)
|
2020-06-15 |
2025-03-21 |
Norton Waterford Ltd |
Inhaler comprising a blister pack
|
|
PL244222B1
(pl)
*
|
2020-09-24 |
2023-12-18 |
Polfarmex Spolka Akcyjna |
Inhalator do podawania leku
|
|
PL244221B1
(pl)
*
|
2020-09-24 |
2023-12-18 |
Polfarmex Spolka Akcyjna |
Inhalator do podawania leku
|
|
US20240148849A1
(en)
|
2021-02-22 |
2024-05-09 |
Glaxosmithkline Biologicals Sa |
Immunogenic composition, use and methods
|
|
WO2022175425A1
(en)
|
2021-02-22 |
2022-08-25 |
Glaxosmithkline Intellectual Property Development Limited |
Inhaled mtor kinase inhibitors for use in the treatment or the prevention of a respiratory rna virus infection
|
|
WO2022179967A1
(en)
|
2021-02-23 |
2022-09-01 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Vadadustat for treating covid-19 in a hospitalized subject
|
|
GB202113921D0
(en)
|
2021-09-29 |
2021-11-10 |
Norton Waterford Ltd |
Dry powder medicament inhaler
|
|
CA3227858A1
(en)
|
2021-09-29 |
2023-04-06 |
Norton (Waterford) Limited |
Dry powder medicament inhaler
|
|
HUE071783T2
(hu)
|
2021-09-29 |
2025-09-28 |
Norton Waterford Ltd |
Szárazporos gyógyszerinhalátor
|
|
ES3031159T3
(en)
|
2021-09-29 |
2025-07-04 |
Norton Waterford Ltd |
Dry powder medicament inhaler
|
|
US20250325759A1
(en)
*
|
2021-12-17 |
2025-10-23 |
Sandoz Ag |
Inhaler device
|
|
US12502490B2
(en)
|
2022-04-29 |
2025-12-23 |
Merxin Ltd |
Manifold
|
|
GB2618145A
(en)
*
|
2022-04-29 |
2023-11-01 |
Merxin Ltd |
Manifold
|
|
WO2024167763A2
(en)
*
|
2023-02-06 |
2024-08-15 |
Transpire Bio Inc. |
Dual strip dry powder inhaler and manifolds for use therein
|
|
WO2025149765A1
(en)
|
2024-01-10 |
2025-07-17 |
Emphasys Importadora Exportadora E Distribuidora Ltda. |
Dry powder inhaler
|